Journal of Hepatology
Издатель: Elsevier · ISSN 0168-8278 · 80 статей
- Quantitative bias analysis of unmeasured confounding refines interpretation of longitudinal associations between cardiometabolic risk factors and liver stiffness in MASLD
- Reply to: Correspondence on “Longitudinal changes in cardiometabolic risk factors are associated with changes in liver stiffness in adults with MASLD”
- Beyond alkaline phosphatase: Can anti–integrin αvβ6 autoantibodies serve as biomarkers in primary sclerosing cholangitis trials?
- Quantifying the delivered dose of bulevirtide in clinical trials and real-world use: A dose recovery study
- Corrigendum to: ‘Generation of hepatobiliary organoids from human induced pluripotent stem cells’ [J Hepatol (2019) 70 (6):1145–1158]
- Systemic therapy for HCC: Doublets, triplets and beyond
- Systemic therapy of biliary tract cancer: The road to personalised strategies
- SETDB1: An epigenetic gatekeeper of antitumor immune organization in HCC
- Temporal assessment of spatial and single-cell transcriptomes identifies CD226-NECTIN2 T cell-cholangiocyte interaction in bile duct inflammation
- Effects of MASH risk genotypes on resmetirom efficacy in patients with MASH and fibrosis
- Can Hepatitis D Remain Hidden? Revisiting HDV Persistence and Mechanisms of Reactivation
- First-line durvalumab and tremelimumab in poor-prognosis unresectable hepatocellular carcinoma: Phase IIIb single-arm SIERRA study
- Abnormal left ventricular mass as a prognostic marker for outcomes in infants and children with cirrhosis
- Reply to: “Comment on surveillance of patients at risk of liver cancer: Expert opinions”
- Controlling the navigation of homing pigeons – a new function for liver macrophages
- Reply to: “Statistical pitfalls in interpreting zero HCC risk and HBsAg clearance in the long-term PAGE-B cohort”: Interpreting HCC risk and HBsAg clearance in the long-term PAGE-B cohort
- Clarification of the ELM score performance tables
- Dialling up success: Next generation treatments in primary biliary cholangitis
- HBs proteins do not reveal their genomic origin
- Semaglutide targets two major drivers of liver disease
- Intestinal Candida albicans promotes HCC progression and anti–PD-1 resistance via IL-17A and Trem2+ macrophages
- HbA1c trajectories and the risk of liver-related events in patients with type 2 diabetes mellitus – Reply to Correa et al.
- Cell-free DNA methylation for detection of early HCC: Promising signals, but not yet a surveillance test
- Crosstalk along the gut–liver axis in liver disease: Clinical and mechanistic aspects
- Acute-on-chronic liver failure: A global multisociety consensus on definitions
- Editorial Board
- Get ready for EASL Congress 2027 and submit your abstract by 19 January!
- Register for the EASL Liver Cancer Summit 2027! 14-16 January, Valencia (Spain)
- Register for the EASL Steatotic Liver Disease Summit 2027! 10-13 February, Berlin (Germany)
- The LIVERAIM project aims to create and validate a biomarker-based screening platform to enable early detection of liver disease in asymptomatic individuals